Latest news
FDA expands Pluvicto label, making it available to most metastatic prostate cancer patients - Endpoints NewsEndpoints News · Mon, 03 Aug 2026 15:26:00 GMTFDA Expands Approval of Pluvicto in Combination with ARPI for PSMA-Positive mAPMN/S Prostate Cancer - diagnosticimaging.comdiagnosticimaging.com · Sat, 01 Aug 2026 13:16:50 GMTAdvanced Bionics Receives FDA Approval for Expanded Cochlear Implant Candidacy Criteria in SSD and AHL - The Hearing ReviewThe Hearing Review · Tue, 28 Jul 2026 16:03:39 GMTHow FDA Approval of SimpleScreen CRC Could Expand Colorectal Cancer Screening With Mark Fendrick, MD - HCPLiveHCPLive · Mon, 27 Jul 2026 20:03:55 GMTVivos Reports FDA IDE Approval and Expands Precision Radionuclide Therapy Programs - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMT